Michaela Schmidtke

Title: Michaela Schmidtke: Innovator in Antiviral Compounds

Introduction

Michaela Schmidtke is a prominent inventor based in Jena, Germany. She has made significant contributions to the field of antiviral agents, holding three patents that showcase her innovative work. Her research focuses on developing compounds that exhibit high activity against various viruses, particularly rhinoviruses and picornaviruses.

Latest Patents

Michaela's latest patents include the development of 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives. These compounds are noted for their manufacture and use as antiviral active substances. The invention relates to derivatives of the general formula I or pharmaceutically acceptable salts or propharmacons thereof. Notably, these compounds demonstrate particularly high activity against viruses and are well-tolerated, making them suitable for treating viral infections. Another patent involves 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, which also serve as antiviral agents.

Career Highlights

Throughout her career, Michaela has worked with notable companies such as Scandion Oncology A/S and Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG. Her work in these organizations has allowed her to further her research and development in antiviral compounds.

Collaborations

Michaela has collaborated with esteemed colleagues, including Peter Wutzler and Hans-Martin Dahse. These partnerships have contributed to her success in the field of antiviral research.

Conclusion

Michaela Schmidtke is a trailblazer in the development of antiviral agents, with a focus on innovative compounds that show promise in treating viral infections. Her contributions to the field are significant and continue to impact the medical community positively.